12.19.25 -- Sponsors Collect Too Much 'Non-Essential' Data, Say Tufts And TransCelerate

Real-world evidence (RWE) offers insights into the effectiveness of medical treatments in everyday settings, with various stakeholders utilize RWE to enhance healthcare.

Tool sprawl in clinical trials creates hidden inefficiencies, fractured collaboration, and delayed insights. Unified systems restore flow, clarity, and control across research teams and functions.

Here, we summarize a webinar on the importance of science-driven decision-making with proactive operational measures to safeguard trial integrity and investment value in schizophrenia research.

Explore how immune profiling and translational models reveal mechanisms, optimize dosing, and advance safer, more precise immunotherapies for the next generation of targeted treatments.

Discover how streamlined workflows and enhanced collaboration between data managers and medical reviewers can boost clinical trial efficiency, improve data quality, and ensure patient safety.

Not all clinical trial metrics tell the full story. Oversimplified stats can mislead, masking complex factors that truly influence enrollment, retention, and operational performance.

Check out how integrating an innovative document review platform streamlines workflows, boosts compliance, and cuts review times by 65% from real-world Life Sciences case studies.

This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.

With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.

Reveal how this program's advanced AI capabilities deliver powerful analytics and reporting, setting a new standard for efficiency and innovation in clinical trials.

This award-winning SaaS platform can be deployed across all phases. Learn about the new capabilities this company offers to upgrade your planning, build assessment libraries, and more.

How do Agentic workflows (with human oversight) unlock data from patient-mediated medical records and convert clinical data and lab PDFs into traceable, submission-ready study data?

Expert guidance for early-phase trials: From Phase 1 to Phase 2, gain high-quality data, meet global regulatory standards, and position your asset for success in later stages and commercial opportunities.

This step-by-step guide helps sponsors and sites prepare for and navigate the various types of audits required at each stage of the clinical trial process.

When risk-based oversight is reduced to a compliance checkbox, critical signals can be missed and escalate into systemic issues.